HomeTrading IdeasUS Dollar Under Pressure...

US Dollar Under Pressure Amid Trump Push and Fed Cut Speculation

  • Dollar slides as Powell sounds more dovish than expected
  • Trump’s bill passes through Senate, pending final vote in House
  • JOLTS job openings and ISM manufacturing PMI reveals some improvement
  • Wall Street pauses uptrend, gold rebounds

Powell Does Not Rule Out a July Rate Cut

The extended its slide against all but one of its major peers on Tuesday, perhaps due to Fed Chair Powell appearing more dovish than expected at the European Central Bank’s annual conference in Sintra, Portugal.

The Fed chief reiterated the view that the Committee will maintain a patient stance when it comes to further interest rate reductions, but he did not rule out a at the July meeting, adding that the decision will depend on incoming data. This allowed investors to continue pricing in 65bps worth of rate cuts by the end of the year, with a 20% chance of the next quarter-point reduction being delivered in July.

A couple of weeks ago, that probability was at zero, but Trump’s continuous criticism of Powell about being too late in lowering borrowing costs, and remarks by a couple of policymakers that they would support a July cut, prompted market participants to reconsider their view.

Perhaps one of the reasons Trump is pushing for lower interest rates maybe because it would make it easier for the government to repay its debt. Let’s not forget that Trump’s tax-cut and spending bill is estimated to add more than $3 trillion to the national debt. The bill passed through the Senate yesterday and will move back to the House for final approval.

US Data Show Improvement, Eurozone Inflation Hits ECB’s Target

As for yesterday’s data, the for May came in higher than expected, while the for June improved somewhat, although it stayed in contractionary territory. This adds extra importance to the and the ISM non-manufacturing PMI, both due out on Thursday, as decent numbers may lower the probability of a July rate cut and perhaps allow the greenback to recover somewhat. The report on private employment is scheduled to be released today.

The Eurozone’s preliminary numbers were also released yesterday. The headline rate ticked up to hit the ECB’s objective of 2%, while the rate, which excludes the volatile items of food and energy, held steady at 2.4% y/y. This allowed investors to continue expecting just one more quarter-point reduction by the ECB before this easing cycle ends. However, instead of expecting it by December, they now believe that it will be delivered in February 2026.

The continued to take advantage of the dollar’s weakness, with euro/dollar hitting a new almost-four-year high yesterday. With the prevailing uptrend in this pair looking very strong, a pullback due to potentially strong US data tomorrow is unlikely to prove a game changer.

Economic Calendar

Stocks Pull Back, but Uptrend Remains Intact; Gold Rebounds

On Wall Street, the and the closed yesterday’s session in the red, while the gained nearly 1%. However, stock futures are pointing to a rebound today and likely a new record high on the S&P 500. Perhaps the slowdown was due to trade-related concerns after US President Trump said that he is not thinking of extending the July 9 deadline for countries to negotiate trade deals with the US. This means that higher levies could be imposed thereafter. In any case, for now, the prospect of lower interest rates is encouraging investors to overall maintain their risk exposure.

extended its rebound yesterday. However, judging by the performance of other asset classes, this is not due to safe haven flows but rather due to a weakening dollar and expectations of lower interest rates. After all, increasing bets mean lower opportunity cost for holding the non-yielding precious metal.

Most Popular

More from Author

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk...

Read Now

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year, I thought it would be a good idea to review the key areas of analysis for the stock market.Such a review includes my...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities, and equities. Central banks once again take the spotlight, with both the Reserve Bank of Australia (RBA) and the Reserve Bank of New...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...